Loading…
A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine
We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inf...
Saved in:
Published in: | Neurology and clinical neuroscience 2022-07, Vol.10 (4), p.223-225 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473 |
---|---|
cites | cdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473 |
container_end_page | 225 |
container_issue | 4 |
container_start_page | 223 |
container_title | Neurology and clinical neuroscience |
container_volume | 10 |
creator | Katada, Eiichi Toyoda, Takanari Yamada, Gohei Morishima, Akira Matsukawa, Noriyuki |
description | We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone. |
doi_str_mv | 10.1111/ncn3.12604 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9115276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2685867607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</originalsourceid><addsrcrecordid>eNp9kc9KAzEQh4MottRefABZ8Ca0Jpts0lyEUv8VSntR8Ray2WybspvU7LZlbz6Cz-iTuGtr0YtzSWA-vhnmB8A5gn1U17VVFvdRSCE5Au0QEt4jiOHjX_8W6BbFEtbFOUZ8cApaOKIQEYLb4HUYKFnowKWBWnhnjQqMTTOZ57J0vgoSnVc6M1aWxs6Dlcsqq9ferWS5qILUZZnbNo3R7GV8-_n-gXiwkUoZq8_ASSqzQnf3bwc83989jR57k9nDeDSc9FQEI9ILCU8ZTjBSMhzoKOQxRjhJOIsxZ1TFMY6Y1IwzFieQ4FAiwpRCkaSUMUYY7oCbnXe1jnOdKG1LLzOx8iaXvhJOGvG3Y81CzN1GcISikNFacLkXePe21kUplm7tbb2zCOkgGlBGYTPmakcp74rC6_QwAUHRBCGaIMR3EDV88XunA_pz9hpAO2BrMl39oxLT0RTvpF9vY5Ob</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685867607</pqid></control><display><type>article</type><title>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Katada, Eiichi ; Toyoda, Takanari ; Yamada, Gohei ; Morishima, Akira ; Matsukawa, Noriyuki</creator><creatorcontrib>Katada, Eiichi ; Toyoda, Takanari ; Yamada, Gohei ; Morishima, Akira ; Matsukawa, Noriyuki</creatorcontrib><description>We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.</description><identifier>ISSN: 2049-4173</identifier><identifier>EISSN: 2049-4173</identifier><identifier>DOI: 10.1111/ncn3.12604</identifier><identifier>PMID: 35601443</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Ataxia ; Case Report ; chronic inflammatory demyelinating polyneuropathy ; COVID-19 ; COVID‐19 vaccine ; Demyelination ; Guillain–Barrẻ syndrome ; Inflammation ; Paresthesia ; Polyneuropathy ; Vaccines</subject><ispartof>Neurology and clinical neuroscience, 2022-07, Vol.10 (4), p.223-225</ispartof><rights>2022 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd.</rights><rights>2022 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</citedby><cites>FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</cites><orcidid>0000-0002-1594-5141</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35601443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katada, Eiichi</creatorcontrib><creatorcontrib>Toyoda, Takanari</creatorcontrib><creatorcontrib>Yamada, Gohei</creatorcontrib><creatorcontrib>Morishima, Akira</creatorcontrib><creatorcontrib>Matsukawa, Noriyuki</creatorcontrib><title>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</title><title>Neurology and clinical neuroscience</title><addtitle>Neurol Clin Neurosci</addtitle><description>We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.</description><subject>Ataxia</subject><subject>Case Report</subject><subject>chronic inflammatory demyelinating polyneuropathy</subject><subject>COVID-19</subject><subject>COVID‐19 vaccine</subject><subject>Demyelination</subject><subject>Guillain–Barrẻ syndrome</subject><subject>Inflammation</subject><subject>Paresthesia</subject><subject>Polyneuropathy</subject><subject>Vaccines</subject><issn>2049-4173</issn><issn>2049-4173</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc9KAzEQh4MottRefABZ8Ca0Jpts0lyEUv8VSntR8Ray2WybspvU7LZlbz6Cz-iTuGtr0YtzSWA-vhnmB8A5gn1U17VVFvdRSCE5Au0QEt4jiOHjX_8W6BbFEtbFOUZ8cApaOKIQEYLb4HUYKFnowKWBWnhnjQqMTTOZ57J0vgoSnVc6M1aWxs6Dlcsqq9ferWS5qILUZZnbNo3R7GV8-_n-gXiwkUoZq8_ASSqzQnf3bwc83989jR57k9nDeDSc9FQEI9ILCU8ZTjBSMhzoKOQxRjhJOIsxZ1TFMY6Y1IwzFieQ4FAiwpRCkaSUMUYY7oCbnXe1jnOdKG1LLzOx8iaXvhJOGvG3Y81CzN1GcISikNFacLkXePe21kUplm7tbb2zCOkgGlBGYTPmakcp74rC6_QwAUHRBCGaIMR3EDV88XunA_pz9hpAO2BrMl39oxLT0RTvpF9vY5Ob</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Katada, Eiichi</creator><creator>Toyoda, Takanari</creator><creator>Yamada, Gohei</creator><creator>Morishima, Akira</creator><creator>Matsukawa, Noriyuki</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1594-5141</orcidid></search><sort><creationdate>202207</creationdate><title>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</title><author>Katada, Eiichi ; Toyoda, Takanari ; Yamada, Gohei ; Morishima, Akira ; Matsukawa, Noriyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ataxia</topic><topic>Case Report</topic><topic>chronic inflammatory demyelinating polyneuropathy</topic><topic>COVID-19</topic><topic>COVID‐19 vaccine</topic><topic>Demyelination</topic><topic>Guillain–Barrẻ syndrome</topic><topic>Inflammation</topic><topic>Paresthesia</topic><topic>Polyneuropathy</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katada, Eiichi</creatorcontrib><creatorcontrib>Toyoda, Takanari</creatorcontrib><creatorcontrib>Yamada, Gohei</creatorcontrib><creatorcontrib>Morishima, Akira</creatorcontrib><creatorcontrib>Matsukawa, Noriyuki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurology and clinical neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katada, Eiichi</au><au>Toyoda, Takanari</au><au>Yamada, Gohei</au><au>Morishima, Akira</au><au>Matsukawa, Noriyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine</atitle><jtitle>Neurology and clinical neuroscience</jtitle><addtitle>Neurol Clin Neurosci</addtitle><date>2022-07</date><risdate>2022</risdate><volume>10</volume><issue>4</issue><spage>223</spage><epage>225</epage><pages>223-225</pages><issn>2049-4173</issn><eissn>2049-4173</eissn><abstract>We report a 44‐year‐old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID‐19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID‐19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID‐19 vaccine alone.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35601443</pmid><doi>10.1111/ncn3.12604</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-1594-5141</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2049-4173 |
ispartof | Neurology and clinical neuroscience, 2022-07, Vol.10 (4), p.223-225 |
issn | 2049-4173 2049-4173 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9115276 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Ataxia Case Report chronic inflammatory demyelinating polyneuropathy COVID-19 COVID‐19 vaccine Demyelination Guillain–Barrẻ syndrome Inflammation Paresthesia Polyneuropathy Vaccines |
title | A case of chronic inflammatory demyelinating polyneuropathy following COVID‐19 vaccine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20chronic%20inflammatory%20demyelinating%20polyneuropathy%20following%20COVID%E2%80%9019%20vaccine&rft.jtitle=Neurology%20and%20clinical%20neuroscience&rft.au=Katada,%20Eiichi&rft.date=2022-07&rft.volume=10&rft.issue=4&rft.spage=223&rft.epage=225&rft.pages=223-225&rft.issn=2049-4173&rft.eissn=2049-4173&rft_id=info:doi/10.1111/ncn3.12604&rft_dat=%3Cproquest_pubme%3E2685867607%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5054-249f73d31ca28e529b313dd97b3976cbb357ae7977bd0432a147cc15a66777473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2685867607&rft_id=info:pmid/35601443&rfr_iscdi=true |